Reversible conduction block of peroneal nerve associated with SARS-CoV-2

Neurol Sci. 2022 Jan;43(1):95-97. doi: 10.1007/s10072-021-05655-8. Epub 2021 Oct 14.

Abstract

Background: The ongoing SARS-CoV-2 pandemic, which is dramatically spreading worldwide, is well known for its respiratory sequelae. Besides cases of Guillain-Barré Syndrome, encephalitis, hyposmia, the whole range of neurological complications due to SARSCoV-2 is still not well known.

Methods and findings: Herein, we report a new case of COVID-19, associated with mononeuropathy with reversible conduction block (CB). After SARS-CoV-2 infection, the patient developed acute weakness of left peroneal muscles. He underwent an endovenous immunoglobulin treatment, and symptoms improved. Two electroneurographic exam (before and after treatment), showed a reversible CB on left peroneal nerve. Dosage of serum antiganglioside antibodies showed anti-GM1 IgM positivity.

Conclusions: The present case gives new informations about reversible CB neuropathy as an acute presentation of SARS-CoV-2. Besides, antiganglioside antibodies evaluation could be useful to understand etiology of the increasing number of neurological manifestations related to SARS-CoV-2.

Keywords: Antiganglioside antibodies; CIDP; COVID-19; Neuroimmunology; Peripheral neuropathy; SARS-CoV-2.

Publication types

  • Case Reports

MeSH terms

  • COVID-19*
  • Guillain-Barre Syndrome* / diagnosis
  • Humans
  • Male
  • Pandemics
  • Peroneal Nerve
  • SARS-CoV-2